Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2026-02-10 @ 11:48 AM
Study NCT ID:
NCT02566967
Status:
COMPLETED
Last Update Posted:
2019-07-05
First Post:
2015-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
Sponsor:
Norman B. Gaylis, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-01
First Submit QC Date:
None
Study First Post Date:
2015-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-02
Last Update Post Date:
2019-07-05
Last Update Post Date Type:
ACTUAL